Markets

Insider Trading

Hedge Funds

Retirement

Opinion

The City with the Lowest Life Expectancy in the World

We recently compiled a list of the 30 Cities with the Lowest Life Expectancy in the World. But in this article, we will focus on the city with the lowest life expectancy in the world and take an overview of the trends in life expectancy across the globe.

Trends in Global Life Expectancy Across the Globe

Global life expectancy has increased dramatically over the years: it stood at just 51 years in 1960, rising to around 71 years in the present decade. Data by the World Health Organization reveals that global life expectancy increased by more than six years between 2000 and 2019 before the pandemic, going from 66.8 years in 2000 to 73.1 years in 2019. Healthy life expectancy (HALE), also grew by 9%, increasing from 58.1 in 2000 to 63.5 in 2019. This increase was primarily due to a decline in mortality instead of a decrease in the number of years people lived with disability. The increase in life expectancy thus surpassed the rise in HALE, at 6.4 years and 5.3 years, respectively.

However, the COVID-19 pandemic reversed around a decade of life expectancy and HALE increase. According to the World Health Statistics 2024 report by the World Health Organization (WHO),  global life expectancy and HALE in 2020 returned to their 2016 levels at 72.5 years and 62.8 years, respectively. 2021 saw a further recession, with the two metrics returning to their 2012 levels. Global life expectancy reduced to 71.4 years, while HALE decreased to 61.9 years. The pandemic thus wiped out a decade of improvement in just two years.

The report also highlighted the unequal effects of these trends across the globe, with WHO regions for Southeast Asia and the Americas suffering the most. Life expectancy in the regions fell by around three years, with healthy life expectancy dropping by 2.5 years between 2019 and 2022. The Western Pacific Region, in contrast, remained minimally affected, experiencing a drop of less than 0.1 years in life expectancy and 0.2 years in healthy life expectancy between 2019 and 2021. You can also look at 15 Countries with the Highest Life Expectancy in Asia for more insight.

Life expectancy in the US underwent a similar decline due to the pandemic. According to the Centers for Disease Control and Prevention, life expectancy for both sexes in the country stands at 77.5 years as of 2022, with 74.8 years for males and 80.2 years for women.

Role of Healthcare and Pharmaceuticals in Managing Life Expectancy

With almost all facets of life returning to normal after the pandemic, global life expectancy is also expected to revert to its pre-pandemic levels. In fact, a study by the Global Burden of Disease forecasted an increase of 4.9 years in the global life expectancy of males and 4.2 years in that of females between 2022 and 2050. These life expectancy increases are anticipated to be the most significant in countries with low life expectancies, allowing a confluence of increasing life expectancies across the globe.

These trends are primarily driven by extensive public health measures that have improved and prevented survival rates from COVID-19, cardiovascular diseases, and several communicable, maternal, neonatal, and nutritional diseases (CMNNs). Overall, almost all countries worldwide are expected to experience an improvement in their average life expectancies, driven by upgrading healthcare and infrastructure. Increased availability of facilities and higher access to nutritional food are also pivotal factors in the domain. Prominent healthcare and pharmaceutical companies are playing their roles in bringing life expectancy back to pre-pandemic levels by introducing advanced treatments and medications to combat death and diseases. Johnson & Johnson (NYSE:JNJ) is a significant player in the field. Headquartered in New Jerse, this multinational pharmaceutical, medical technologies, and biotechnology corporation holds expertise in Innovative Medicine and MedTech domains and operates under several business units, including DePuy Synthes, Neutrogena Corporation, Ethicon, Janssen Pharmaceuticals, and Acclarent.

On August 2nd, DePuy Synthes, which is the Orthopaedics Company of Johnson & Johnson (NYSE:JNJ), announced the launch of VELYS™ Active Robotic-Assisted System, also known as VELYS™ SPINE. Developed in collaboration with eCential Robotics, this dual-use robotics and standalone navigation platform is one of a kind, allowing surgeons to tackle the most complex challenges with its active robotics technology. The platform will be used in planning and instrumenting spinal fusion procedures in the thoracolumbar, cervical, and sacroiliac spine. The company’s continued digital advancements in the field of surgical robotics and navigation have established it as a leader in the domain.

Johnson & Johnson (NYSE:JNJ) is also seeking FDA approval for the first and only monotherapy available for adults with treatment-resistant depression: SPRAVATO®(esketamine). Results from the fourth phase of SPRAVATO® monotherapy data show quick improvement in depression symptoms, building on more than a decade of clinical trials and research. This monotherapy nasal spray will allow patients living with treatment-resistant depression, preventing them from jumping from one treatment to another that fail to curb their symptoms. The Johnson & Johnson (NYSE:JNJ) MedTech unit supports technology that is applied in approximately 75 million medical procedures every year, and announced plans in March to collaborate with Nvidia (NASDAQ:NVDA) to develop new artificial intelligence applications for surgery. The companies plan to employ Artificial Intelligence within surgical platforms and devices to help surgeons from pre-op to post-op, automating and streamlining the procedures.

Now that we have taken an overview of the trends in life expectancy around the globe, let’s look at the citiy with the lowest life expectancy in the world. You can also look at 20 US Cities With the Shortest Life Expectancy and 15 Countries with the Highest Life Expectancy in Africa.

Pixabay/Public Domain

Our Methodology

To compile a list of the 30 cities with the lowest life expectancy in the world, we considered the Central Intelligence Agency’s (CIA) list of average life expectancy of countries across the globe. We shortlisted the 30 countries with the lowest life expectancy in the world, and used that as a proxy for the life expectancies of their largest cities. The 30 cities with the lowest life expectancy in the world are arranged in descending order of their average life expectancy as of 2024.

At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

The City with the Lowest Life Expectancy in the World

1. Kabul, Afghanistan

Average Life Expectancy as of 2024:  54.4 Years 

Kabul ranks first on our list of the 30 cities with the lowest life expectancy in the world. It is the capital and largest city of Afghanistan, a landlocked country located at the connecting point of South Asia and Central Asia. Afghanistan has been suffering from decades of war, inadequate administrative practices, and failing infrastructure, which are some of the primary reasons behind the country’s low life expectancy. Kabul is located in the eastern half of the country and forms a part of the Kabul Province as a municipality. It is divided into 22 municipal districts for administration and houses around 4.95 million people as of 2023. The city has an average life expectancy of around 54.4 years as of 2024, the lowest in the world.

If you are interested in learning about other cities with the lowest life expectancy in the world, take a look at our detailed report on 30 Cities with the Lowest Life Expectancy in the World.

At Insider Monkey, we delve into a variety of topics; however, our expertise lies in identifying the top-performing stocks. Currently, Artificial Intelligence (AI) technology stands out as one of the most promising fields. If you are looking for an AI stock that is more promising than NVDA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: Analyst Sees a New $25 Billion “Opportunity” for NVIDIA and Jim Cramer is Recommending These 10 Stocks in June.

Disclosure: None. This article is originally published on Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!